PharmD Info

A forum for Indian Pharmacy Professionals

New Drug Information's and other safety information, drug label changes, and Dose and Dosage Calculations, CDCSO,PvPI and FDA Safety Alerts and etc.
  • User avatar
#2862
The first medicine designed to prevent migraines was approved by the Food and Drug Administration on Thursday, ushering in what many experts believe will be a new era in treatment for people who suffer the most severe form of these headaches.

The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. The list price will be $6,900 a year, and Amgen said the drug will be available to patients within a week.

References:

https://www.fda.gov/newsevents/newsroom ... 608120.htm

FIP provides a wide selection of digital events t[…]

Looking for Ideas to celebrate Pharmacist Day? Cel[…]

Online Plagiarism Checker

To get most accurate results, we use Plagiarism C[…]

Good Chromatography Practices - WHO Technical Repo[…]

PharmD Info - Highlights